Isoprostanes - Prostaglandin-like compounds formed in vivo independently of cyclooxygenase - Use as clinical indicators of oxidant damage

被引:62
作者
Awad, JA [1 ]
Roberts, JL [1 ]
Burk, RF [1 ]
Morrow, JD [1 ]
机构
[1] VANDERBILT UNIV,DIV CLIN PHARMACOL,NASHVILLE,TN
关键词
D O I
10.1016/S0889-8553(05)70255-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
F-2-isoprostanes are prostanoids produced independently of cyclooxygenase by free radical-catalyzed peroxidation of arachidonic acid containing lipids. Quantification of F-2-isoprostanes from biological fluids and tissues represents an important advance in the detection and measurement of lipid peroxidation in vivo. In addition, the biophysical effects of isoprostane-containing lipids and the biological effects of free isoprostanes provide potential mechanisms for oxidant stress-related alterations in homeostasis. F-2-isoprostane measurement in experimental models of free radical-induced injury and human disease may allow better design and evaluation of antioxidant therapeutic strategies.
引用
收藏
页码:409 / &
页数:21
相关论文
共 74 条
[31]  
KAYGANICHHARRISON KA, 1993, J LIPID RES, V34, P1229
[32]   INTRAVENOUS ACETYLCYSTEINE IN PARACETAMOL INDUCED FULMINANT HEPATIC-FAILURE - A PROSPECTIVE CONTROLLED TRIAL [J].
KEAYS, R ;
HARRISON, PM ;
WENDON, JA ;
FORBES, A ;
GOVE, C ;
ALEXANDER, GJM ;
WILLIAMS, R .
BRITISH MEDICAL JOURNAL, 1991, 303 (6809) :1026-1029
[33]  
KINSELLA BT, 1995, FASEB J, V9, pA40
[34]   ETHANOL OXIDATION BY HEPATIC MICROSOMES - ADAPTIVE INCREASE AFTER ETHANOL FEEDING [J].
LIEBER, CS ;
DECARLI, LM .
SCIENCE, 1968, 162 (3856) :917-&
[35]   EFFECT OF OXYGEN-TENSION ON THE GENERATION OF F-2-ISOPROSTANES AND MALONDIALDEHYDE IN PEROXIDIZING RAT-LIVER MICROSOMES [J].
LONGMIRE, AW ;
SWIFT, LL ;
ROBERTS, LJ ;
AWAD, JA ;
BURK, RF ;
MORROW, JD .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (07) :1173-1177
[36]   LIPID-PEROXIDATION AS MOLECULAR MECHANISM OF LIVER-CELL INJURY DURING REPERFUSION AFTER ISCHEMIA [J].
MATHEWS, WR ;
GUIDO, DM ;
FISHER, MA ;
JAESCHKE, H .
FREE RADICAL BIOLOGY AND MEDICINE, 1994, 16 (06) :763-770
[37]  
MATHEWS WR, 1993, P 41 ASMS C MASS SPE, pA865
[38]  
MCCORD JM, 1985, NEW ENGL J MED, V312, P159
[39]  
MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185
[40]  
MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211